PDCD1 and breast cancer: Among these, ICIs targeting programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) have been extensively studied in BC, showing promising results in specific subtypes [7, 8].